These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7570890)

  • 61. The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children.
    Ogutu BR; Smoak BL; Nduati RW; Mbori-Ngacha DA; Mwathe F; Shanks GD
    Trans R Soc Trop Med Hyg; 2000; 94(1):83-4. PubMed ID: 10748907
    [No Abstract]   [Full Text] [Related]  

  • 62. Comparative effects of pyrimethamine-sulfadoxine, with and without probenecid, on Plasmodium falciparum gametocytes in children with acute, uncomplicated malaria.
    Sowunmi A; Adedeji AA; Fateye BA; Fehintola FA
    Ann Trop Med Parasitol; 2004 Dec; 98(8):873-8. PubMed ID: 15667719
    [No Abstract]   [Full Text] [Related]  

  • 63. Effect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria.
    Obonyo CO; Taylor W; Ekvall H; Kaneko A; Ter Kuile F; Olliaro P; Bjorkman A; Oloo AJ
    Ann Trop Med Parasitol; 2007 Jun; 101(4):281-95. PubMed ID: 17524243
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
    Koram KA; Abuaku B; Duah N; Quashie N
    Acta Trop; 2005 Sep; 95(3):194-203. PubMed ID: 16054584
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sulfadoxine-pyrimethamine effectiveness against Plasmodium falciparum malaria in Mpumalanga Province, South Africa.
    Govere JM; la Grange JJ; Durrheim DN; Freese JA; Sharp BL; Mabuza A; Mngomezulu N; Bredenkamp BL
    Trans R Soc Trop Med Hyg; 1999; 93(6):644. PubMed ID: 10717756
    [No Abstract]   [Full Text] [Related]  

  • 66. Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria.
    Metzger W; Mordmüller B; Graninger W; Bienzle U; Kremsner PG
    J Antimicrob Chemother; 1995 Oct; 36(4):723-8. PubMed ID: 8591949
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.
    Mockenhaupt FP; Ehrhardt S; Dzisi SY; Teun Bousema J; Wassilew N; Schreiber J; Anemana SD; Cramer JP; Otchwemah RN; Sauerwein RW; Eggelte TA; Bienzle U
    Trop Med Int Health; 2005 Jun; 10(6):512-20. PubMed ID: 15941413
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
    Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine.
    Zakeri S; Farahani MS; Afsharpad M; Salehi M; Raeisi A; Djadid ND
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e123-8. PubMed ID: 20399698
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.
    Mishra S; Bharti PK; Shukla MM; Ali NA; Kashyotia SS; Kumar A; Dhariwal AC; Singh N
    Pathog Glob Health; 2017 Jun; 111(4):186-194. PubMed ID: 28549390
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum must be delayed in Africa.
    Rieckmann K; Cheng Q
    Trends Parasitol; 2002 Jul; 18(7):293-4; author reply 294. PubMed ID: 12379946
    [No Abstract]   [Full Text] [Related]  

  • 72. A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Sagara I; Dicko A; Djimde A; Guindo O; Kone M; Tolo Y; Thera MA; Sogoba M; Fofana M; Ouattara A; Sissoko M; Jansen HF; Doumbo OK
    Am J Trop Med Hyg; 2006 Oct; 75(4):630-6. PubMed ID: 17038684
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pyrimethamine/sulfadoxine for falciparum malaria.
    Watt G; Shanks GD
    Lancet; 1991 Sep; 338(8768):700-1. PubMed ID: 1679503
    [No Abstract]   [Full Text] [Related]  

  • 74. Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine.
    Marks F; von Kalckreuth V; Kobbe R; Adjei S; Adjei O; Horstmann RD; Meyer CG; May J
    J Infect Dis; 2005 Dec; 192(11):1962-5. PubMed ID: 16267768
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.
    Djimdé AA; Fofana B; Sagara I; Sidibe B; Toure S; Dembele D; Dama S; Ouologuem D; Dicko A; Doumbo OK
    Am J Trop Med Hyg; 2008 Mar; 78(3):455-61. PubMed ID: 18337343
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Probable resistance to parenteral artemether in Plasmodium falciparum: case reports from Mumbai (Bombay), India.
    Gogtay NJ; Kadam VS; Karnad DR; Kanbur A; Kamtekar KD; Kshirsagar NA
    Ann Trop Med Parasitol; 2000 Jul; 94(5):519-20. PubMed ID: 10983565
    [No Abstract]   [Full Text] [Related]  

  • 77. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.
    Kshirsagar NA; Gogtay NJ; Rajgor D; Dalvi SS; Wakde M
    Ann Trop Med Parasitol; 2000 Mar; 94(2):189-90. PubMed ID: 10827874
    [No Abstract]   [Full Text] [Related]  

  • 79. Efficacies of chloroquine, pyrimethamine/sulphadoxine and pyrimethamine/sulphalene against P. falciparum in northeastern Nigeria.
    Molta NB; Daniel HI; Watila IM; Oguche SO; Otu TI; Ameh JO; Gadzama NM
    J Trop Med Hyg; 1992 Aug; 95(4):253-9. PubMed ID: 1495121
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire.
    Wolday D; Kibreab T; Bukenya D; Hodes R
    Trans R Soc Trop Med Hyg; 1995; 89(6):654-6. PubMed ID: 8594686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.